What is the evidence supporting the treatment of hypertriglyceridemia in patients with chronic kidney disease (CKD)?
Evidence shows that combination therapies, such as statins with either ezetimibe or fenofibric acid, are effective in treating hypertriglyceridemia while being safe in patients with chronic kidney disease. Ongoing trials can further elucidate the safety and efficacy of newer agents like pemafibrate.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-10
- DOI
- https://doi.org/10.5281/zenodo.24119872
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00